CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BIO-PATH HOLDINGS, INC.

BPTH
$2MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for BPTH. That does not mean none is planned.

Get an email about BPTH's next catalysts

Track BIO-PATH HOLDINGS (BPTH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaBELLAIRE1 employees

Frequently asked questions

What is in BIO-PATH HOLDINGS, INC.'s drug pipeline?β†’

CatalystAlert tracks 2 drug candidates in BIO-PATH HOLDINGS, INC.'s (BPTH) pipeline across Phase 2. Its lead program is BP1001 in combination with Ventoclax plus decitabine (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is BIO-PATH HOLDINGS, INC.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for BIO-PATH HOLDINGS, INC. (BPTH) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track BPTH biotech catalysts?β†’

Add BPTH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BIO-PATH HOLDINGS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply